User Reviews for Brolucizumab
Also known as: Beovu
Reviews may be moderated or edited before publication to correct grammar and spelling or to remove inappropriate language and content. Reviews that appear to be created by parties with a vested interest in the medication will not be published. As reviews and ratings are subjective and self-reported, this information should not be used as the basis for any statistical analysis or scientific studies.
Beovu (brolucizumab) for Macular Degeneration: “Has been working much better than Eylea or lucentis and so much better not have to be injected every 30 days.”
This information is NOT intended to endorse any particular medication. While these reviews might be helpful, they are not a substitute for the expertise, knowledge and judgement of healthcare practitioners.
More about brolucizumab
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Patient Tips
- En Español
- 1 Review
- Drug class: anti-angiogenic ophthalmic agents
- Other brands